|
|
Previous Article | Table of Contents | Next Article 
Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-
mpl-deficient mice
K Carver-Moore, HE Broxmeyer, SM Luoh, S Cooper, J Peng, SA Burstein, MW Moore and FJ de Sauvage
Department of Molecular Oncology, Genentech, Inc, South San Francisco, CA
94080, USA.
Thrombopoietin (TPO), the ligand for the c-mpl receptor, has been shown to
be the major regulator of platelet production. Mice deficient in either
c-mpl or TPO generated by homologous recombination show a dramatic decrease
in platelet counts, but other blood cell counts are normal. Because TPO
treatment of myelosuppressed mice not only enhances the recovery of
platelets but also accelerates erythroid recovery, we investigated the
levels of myeloid and erythroid progenitor cells in TPO-or c-mpl-deficient
mice. Our results show that the number of megakaryocyte,
granulocyte-macrophage, erythroid, and multilineage progenitors are
significantly reduced in the bone marrow, spleen, and peripheral blood of
either TPO-or c-mpl-deficient mice. Administration of recombinant murine
TPO to TPO-deficient mice and control littermate mice significantly
increased the absolute number of myeloid, erythroid, and mixed progenitors
in bone marrow and spleen. This increase was especially apparent in
TPO-deficient mice where numbers were increased to a level greater than in
diluent-treated control mice and approached or equaled that in the
TPO-treated control mice. Moreover, TPO- administration greatly increased
the number of circulating progenitors as well as platelets in both
TPO-deficient and control mice. Furthermore, the megakaryocytopoietic
activity of other cytokines in the absence of a functional TPO or c-mpl
gene was shown both in vitro and in vivo.
Volume 88,
Issue 3,
pp. 803-808,
08/01/1996
Copyright © 1996 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Savoia, C. Dufour, F. Locatelli, P. Noris, C. Ambaglio, V. Rosti, M. Zecca, S. Ferrari, F. di Bari, A. Corcione, et al.
Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations
Haematologica,
September 1, 2007;
92(9):
1186 - 1193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Broxmeyer, S. Sehra, S. Cooper, L. M. Toney, S. Kusam, J. J. Aloor, C. C. Marchal, M. C. Dinauer, and A. L. Dent
Aberrant Regulation of Hematopoiesis by T Cells in BAZF-Deficient Mice
Mol. Cell. Biol.,
August 1, 2007;
27(15):
5275 - 5285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Srivastava, E. Nedelcu, B. Esmaeli-Azad, R. Mishra, and E. Carrier
Thrombopoietin Enhances Generation of CD34+ Cells from Human Embryonic Stem Cells
Stem Cells,
June 1, 2007;
25(6):
1456 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ito, C. R. Mantel, M.-K. Han, S. Basu, S. Fukuda, S. Cooper, and H. E. Broxmeyer
Mad2 is required for optimal hematopoiesis: Mad2 associates with c-Kit in MO7e cells
Blood,
March 1, 2007;
109(5):
1923 - 1930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Buza-Vidas, J. Antonchuk, H. Qian, R. Mansson, S. Luc, S. Zandi, K. Anderson, S. Takaki, J. M. Nygren, C. T. Jensen, et al.
Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK
Genes & Dev.,
August 1, 2006;
20(15):
2018 - 2023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Katsumoto, Y. Aikawa, A. Iwama, S. Ueda, H. Ichikawa, T. Ochiya, and I. Kitabayashi
MOZ is essential for maintenance of hematopoietic stem cells.
Genes & Dev.,
May 15, 2006;
20(10):
1321 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Priddle, D. R. E. Jones, P. W. Burridge, and R. Patient
Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in Stem Cell Therapies
Stem Cells,
April 1, 2006;
24(4):
815 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Metcalf, M. R. Carpinelli, C. Hyland, S. Mifsud, L. DiRago, N. A. Nicola, D. J. Hilton, and W. S. Alexander
Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene
Blood,
May 1, 2005;
105(9):
3480 - 3487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Antonchuk, C. D. Hyland, D. J. Hilton, and W. S. Alexander
Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors
Blood,
September 1, 2004;
104(5):
1306 - 1313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Moliterno, D. M. Williams, L. I. Gutierrez-Alamillo, R. Salvatori, R. G. Ingersoll, and J. L. Spivak
Mpl Baltimore: A thrombopoietin receptor polymorphism associated with thrombocytosis
PNAS,
August 3, 2004;
101(31):
11444 - 11447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Henckaerts, J. C. Langer, and H.-W. Snoeck
Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice
Blood,
July 15, 2004;
104(2):
374 - 379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Inagaki, T. Oda, Y. Naka, H. Shinkai, N. Komatsu, and H. Iwamura
Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities
Blood,
July 1, 2004;
104(1):
58 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Bradley, C. Couldrey, and K. D. Bunting
Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness
Blood,
April 15, 2004;
103(8):
2965 - 2972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kirito, N. Fox, and K. Kaushansky
Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells
Blood,
November 1, 2003;
102(9):
3172 - 3178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C.R. Perlingeiro, M. Kyba, S. Bodie, and G. Q. Daley
A Role for Thrombopoietin in Hemangioblast Development
Stem Cells,
May 1, 2003;
21(3):
272 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xie, R. J. Chan, S. A. Johnson, M. Starr, J. McCarthy, R. Kapur, and M. C. Yoder
Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs
Blood,
February 15, 2003;
101(4):
1329 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood,
December 15, 2002;
100(13):
4272 - 4290.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Kuter and C. G. Begley
Recombinant human thrombopoietin: basic biology and evaluation of clinical studies
Blood,
November 15, 2002;
100(10):
3457 - 3469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Challier, L. Cocault, R. Berthier, N. Binart, I. Dusanter-Fourt, G. Uzan, and M. Souyri
The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells
Blood,
August 28, 2002;
100(6):
2063 - 2070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushansky, N. Fox, N. L. Lin, and W. C. Liles
Lineage-specific growth factors can compensate for stem and progenitor cell deficiencies at the postprogenitor cell level: an analysis of doubly TPO- and G-CSF receptor-deficient mice
Blood,
May 15, 2002;
99(10):
3573 - 3578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Basser, E. O'Flaherty, M. Green, M. Edmonds, J. Nichol, D. M. Menchaca, B. Cohen, and C. G. Begley
Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor
Blood,
April 1, 2002;
99(7):
2599 - 2602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Bunting, H. L. Bradley, T. S. Hawley, R. Moriggl, B. P. Sorrentino, and J. N. Ihle
Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5
Blood,
January 15, 2002;
99(2):
479 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, C. Yang, Y. Xia, A. Bertino, J. Glaspy, M. Roberts, and D. J. Kuter
Thrombocytopenia caused by the development of antibodies to thrombopoietin
Blood,
December 1, 2001;
98(12):
3241 - 3248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kaser, G. Brandacher, W. Steurer, S. Kaser, F. A. Offner, H. Zoller, I. Theurl, W. Widder, C. Molnar, O. Ludwiczek, et al.
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Blood,
November 1, 2001;
98(9):
2720 - 2725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. I. Pestina, J. L. Cleveland, C. Yang, G. P. Zambetti, and C. W. Jackson
Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis
Blood,
October 1, 2001;
98(7):
2084 - 2090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dybedal, D. Bryder, A. Fossum, L. S. Rusten, and S. E. W. Jacobsen
Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells
Blood,
September 15, 2001;
98(6):
1782 - 1791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Levin, L. Cocault, C. Demerens, C. Challier, M. Pauchard, J. Caen, and M. Souyri
Thrombocytopenic c-mpl{-}/{-} mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response
Blood,
August 15, 2001;
98(4):
1019 - 1027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Farese, W. G. Smith, J. G. Giri, N. Siegel, J. P. McKearn, and T. J. MacVittie
Promegapoietin-1a, an Engineered Chimeric IL-3 and Mpl-L Receptor Agonist, Stimulates Hematopoietic Recovery in Conventional and Abbreviated Schedules Following Radiation-Induced Myelosuppression in Nonhuman Primates
Stem Cells,
July 1, 2001;
19(4):
329 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ballmaier, M. Germeshausen, H. Schulze, K. Cherkaoui, S. Lang, A. Gaudig, S. Krukemeier, M. Eilers, G. Strau{beta}, and K. Welte
c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia
Blood,
January 1, 2001;
97(1):
139 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S M Aronica, A Dozier, P Fanti, and M Nazareth
Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin
Lupus,
May 1, 2000;
9(4):
271 - 277.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Vannucchi, F. Paoletti, S. Linari, C. Cellai, R. Caporale, P. R. Ferrini, M. Sanchez, G. Migliaccio, and A. R. Migliaccio
Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice
Blood,
April 15, 2000;
95(8):
2559 - 2568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-S. Luo, K. Ogata, N. Yokose, T. Kato, and K. Dan
Effect of Thrombopoietin on Proliferation of Blasts from Patients with Myelodysplastic Syndromes
Stem Cells,
March 1, 2000;
18(2):
112 - 119.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S.-M. Luoh, E. Stefanich, G. Solar, H. Steinmetz, T. Lipari, T. I. Pestina, C. W. Jackson, and F. J. de Sauvage
Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo
Mol. Cell. Biol.,
January 15, 2000;
20(2):
507 - 515.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. R. Moliterno and J. L. Spivak
Posttranslational Processing of the Thrombopoietin Receptor Is Impaired in Polycythemia Vera
Blood,
October 15, 1999;
94(8):
2555 - 2561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Barosi
Myelofibrosis With Myeloid Metaplasia: Diagnostic Definition and Prognostic Classification for Clinical Studies and Treatment Guidelines
J. Clin. Oncol.,
September 1, 1999;
17(9):
2954 - 2954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ihara, E. Ishii, M. Eguchi, H. Takada, A. Suminoe, R. A. Good, and T. Hara
Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia
PNAS,
March 16, 1999;
96(6):
3132 - 3136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stoffel, S. Ziegler, N. Ghilardi, B. Ledermann, F. J. de Sauvage, and R. C. Skoda
Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo
PNAS,
January 19, 1999;
96(2):
698 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kato, A. Matsumoto, K. Ogami, T. Tahara, H. Morita, and H. Miyazaki
Native Thrombopoietin: Structure and Function
Stem Cells,
September 1, 1998;
16(5):
322 - 328.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Jacob, J. S. Haug, S. Raptis, and D. C. Link
Specific Signals Generated by the Cytoplasmic Domain of the Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Are Not Required for G-CSF-Dependent Granulocytic Differentiation
Blood,
July 15, 1998;
92(2):
353 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsunaga, T. Kato, H. Miyazaki, and M. Ogawa
Thrombopoietin Promotes the Survival of Murine Hematopoietic Long-Term Reconstituting Cells: Comparison With the Effects of FLT3/FLK-2 Ligand and Interleukin-6
Blood,
July 15, 1998;
92(2):
452 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushansky
Thrombopoietin and the Hematopoietic Stem Cell
Blood,
July 1, 1998;
92(1):
1 - 3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Solar, W. G. Kerr, F. C. Zeigler, D. Hess, C. Donahue, F. J. de Sauvage, and D. L. Eaton
Role of c-mpl in Early Hematopoiesis
Blood,
July 1, 1998;
92(1):
4 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Metcalf
Lineage commitment in the progeny of murine hematopoietic preprogenitor cells: Influence of thrombopoietin and interleukin 5
PNAS,
May 26, 1998;
95(11):
6408 - 6412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Abina, M. Tulliez, M.-T. Duffour, N. Debili, C. Lacout, J.-L. Villeval, F. Wendling, W. Vainchenker, and H. Haddada
Thrombopoietin (TPO) Knockout Phenotype Induced by Cross-Reactive Antibodies Against TPO Following Injection of Mice with Recombinant Adenovirus Encoding Human TPO
J. Immunol.,
May 1, 1998;
160(9):
4481 - 4489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gainsford, A. W. Roberts, S. Kimura, D. Metcalf, G. Dranoff, R. C. Mulligan, C. G. Begley, L. Robb, and W. S. Alexander
Cytokine Production and Function in c-mpl-Deficient Mice: No Physiologic Role for Interleukin-3 in Residual Megakaryocyte and Platelet Production
Blood,
April 15, 1998;
91(8):
2745 - 2752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Moliterno, W. D. Hankins, and J. L. Spivak
Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera
N. Engl. J. Med.,
February 26, 1998;
338(9):
572 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood,
February 15, 1998;
91(4):
1101 - 1134.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kimura, A. W. Roberts, D. Metcalf, and W. S. Alexander
Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin
PNAS,
February 3, 1998;
95(3):
1195 - 1200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hong, D. Dumenil, B. van der Loo, F. Goncalves, W. Vainchenker, and J. D. Erusalimsky
Protein Kinase C Mediates the Mitogenic Action of Thrombopoietin in c-Mpl-Expressing UT-7 Cells
Blood,
February 1, 1998;
91(3):
813 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Murone, D. A. Carpenter, and F. J. de Sauvage
Hematopoietic Deficiencies in c-mpl and TPO Knockout Mice
Stem Cells,
January 1, 1998;
16(1):
1 - 6.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Shibuya, H. Akahori, K. Takahashi, E. Tahara, T. Kato, and H. Miyazaki
Multilineage Hematopoietic Recovery by a Single Injection of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Myelosuppressed Mice
Blood,
January 1, 1998;
91(1):
37 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Villeval, K. Cohen-Solal, M. Tulliez, S. Giraudier, J. Guichard, S. A. Burstein, E. M. Cramer, W. Vainchenker, and F. Wendling
High Thrombopoietin Production by Hematopoietic Cells Induces a Fatal Myeloproliferative Syndrome in Mice
Blood,
December 1, 1997;
90(11):
4369 - 4383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ritchie, A. Gotoh, J. Gaddy, S. E. Braun, and H. E. Broxmeyer
Thrombopoietin Upregulates the Promoter Conformation of p53 in a Proliferation-Independent Manner Coincident With a Decreased Expression of Bax: Potential Mechanisms for Survival Enhancing Effects
Blood,
December 1, 1997;
90(11):
4394 - 4402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Weich, A. Wang, M. Fitzgerald, T. Y. Neben, D. Donaldson, J. Giannotti, J. Yetz-Aldape, R. M. Leven, and K. J. Turner
Recombinant Human Interleukin-11 Directly Promotes Megakaryocytopoiesis In Vitro
Blood,
November 15, 1997;
90(10):
3893 - 3902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bunting, R. Widmer, T. Lipari, L. Rangell, H. Steinmetz, K. Carver-Moore, M. W. Moore, G.-A. Keller, and F. J. de Sauvage
Normal Platelets and Megakaryocytes Are Produced In Vivo in the Absence of Thrombopoietin
Blood,
November 1, 1997;
90(9):
3423 - 3429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tropel, V. Roullot, M. Vernet, C. Poujol, H. Pointu, P. Nurden, G. Marguerie, and D. Tronik-Le Roux
A 2.7-kb Portion of the 5' Flanking Region of the Murine Glycoprotein alpha IIb Gene Is Transcriptionally Active in Primitive Hematopoietic Progenitor Cells
Blood,
October 15, 1997;
90(8):
2995 - 3004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Doubeikovski, G. Uzan, Z. Doubeikovski, M.-H. Prandini, F. Porteu, S. Gisselbrecht, and I. Dusanter-Fourt
Thrombopoietin-induced Expression of the Glycoprotein IIb Gene Involves the Transcription Factor PU.1/Spi-1 in UT7-Mpl Cells
J. Biol. Chem.,
September 26, 1997;
272(39):
24300 - 24307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Nandurkar, L. Robb, D. Tarlinton, L. Barnett, F. Kontgen, and C. G. Begley
Adult Mice With Targeted Mutation of the Interleukin-11 Receptor (IL11Ra) Display Normal Hematopoiesis
Blood,
September 15, 1997;
90(6):
2148 - 2159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. J. Borge, V. Ramsfjell, L. Cui, and S. E.W. Jacobsen
Ability of Early Acting Cytokines to Directly Promote Survival and Suppress Apoptosis of Human Primitive CD34+CD38- Bone Marrow Cells With Multilineage Potential at the Single-Cell Level: Key Role of Thrombopoietin
Blood,
September 15, 1997;
90(6):
2282 - 2292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Broudy, N. L. Lin, D. F. Sabath, T. Papayannopoulou, and K. Kaushansky
Human Platelets Display High-Affinity Receptors for Thrombopoietin
Blood,
March 15, 1997;
89(6):
1896 - 1904.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|